ARCHIVES

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

FASEB Urges Better Funding, Management Of Biomedical Research

February 23, 1996

Proof of principle needed before launching “big science” program, advisors say.

March 11, 2005

Richard Bloch’s Dream Of Empowering Patients Had Rough Beginning

October 11, 1996

DCT Board Oks Recompetition Of Master Agreement For BRM Trials

February 4, 1983

ASCO Urges Increase In Research Funding, Removal of Barriers For Trial Participation

January 23, 2009

Appropriations Committees Lean Toward Adding Some To NCI Budget; ACS To Ask Again For $1.5 Billion

April 20, 1984